NetraMark
Toronto
About NetraMark
NetraMark is an AI and the pharma-tech company that has developed proprietary solutions for pharmaceutical and biotechnology companies. These solutions allow clients to leverage small to large data in order to optimize clinical trials and drug development. This is accomplished by providing a superior understanding of their patient populations and these insights are also used to develop new drugs and nutraceuticals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $6.6M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jan 2026)
- Ticker: cnsx:AIAI
- Website: netramark.com
Industries & Categories
Artificial Intelligence (AI), Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/netramark-122916 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.